Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Pacific Biosciences of California Inc
SWB:P09

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
SWB:P09
Watchlist
Price: 1.1205 EUR -10.29% Market Closed
Market Cap: €2.9B
Write Note Create Alert Ask AI

Wall St Price Targets

P09 Price Targets Summary
Pacific Biosciences of California Inc

Wall Street analysts forecast P09 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for P09 is 1.7465 EUR with a low forecast of 1.0809 EUR and a high forecast of 2.6969 EUR.

P09 Lowest Forecast
Wall Street Target
€1.0809
-4% Downside
P09 Average Forecast
Wall Street Target
€1.7465
56% Upside
P09 Highest Forecast
Wall Street Target
€2.6969
141% Upside
Lowest Forecast
Price Target
1.0809 EUR
4% Downside
Average Forecast
Price Target
1.7465 EUR
56% Upside
Highest Forecast
Price Target
2.6969 EUR
141% Upside
Pacific Biosciences of California Inc Competitors:
Price Targets

Revenue
Forecast

15% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.

What are analyst estimates?

Gross Profit
Forecast

36% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
36% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Continue P09 Research

Summary
P09 intrinsic value, competitors valuation, and company profile.
DCF Valuation
P09 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
P09 stock valuation using valuation multiples.
Wall St Estimates
P09 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
P09 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Pacific Biosciences of California Inc listings:
NASDAQ • USD
PACB
 F • EUR
P09
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is P09's stock price target?
Price Target
1.7465 EUR

According to Wall Street analysts, the average 1-year price target for P09 is 1.7465 EUR with a low forecast of 1.0809 EUR and a high forecast of 2.6969 EUR.

What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.

What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.